Taiwan-based vaccine maker Medigen will conduct a Phase 3 clinical trial for its COVID-19 vaccine in Europe once it has received approval from European authorities, which would help pave the way for its entry into European and other international markets, the company announced Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Wei Tzu-chien takes WPA top spot as world No. 1 female pool player
08/08/2025 08:46 PM - Society
Tropical Storm Podul may impact Taiwan as it shifts northward: CWA
08/08/2025 08:11 PM - Business
Taiwan's exports hit new high in July
08/08/2025 07:43 PM - Business
Taiwan shares edge up as TSMC falls back from new high
08/08/2025 05:00 PM - Politics
Legislature takes step in bid to abolish Control Yuan
08/08/2025 04:55 PM